Gonorrhea and Pelvic Inflammatory Disease: Complications, Fertility Impact, and Prevention
Neisseria gonorrhoeae ascends from the cervix to the upper genital tract in 10–20% of untreated women, causing pelvic inflammatory disease (PID). PID triggers inflammation, fibrosis, and scarring of the fallopian tubes, ovaries, and uterus.
Severe Sequelae
- Tubal factor infertility: Bilateral tubal occlusion — 10–15% after 1 PID episode, 35% after 2, 75% after 3.
- Ectopic pregnancy: 6–10× increased risk due to impaired tubal transport.
- Chronic pelvic pain: Adhesions, nerve entrapment — 18–30% of PID survivors.
- Tubo-ovarian abscess (TOA): Requires IV antibiotics ± drainage; may necessitate salpingo-oophorectomy.
- Hysterectomy: Rare, for uncontrolled TOA, hemorrhage, or refractory pain.
Critical Window
Treatment within 48–72 hours of symptom onset drastically reduces long-term damage. CDC regimen: Ceftriaxone 500 mg IM (1 g if ≥150 kg) + Doxycycline 100 mg BID × 7 days ± Metronidazole.
Prevention
- Annual screening (NAAT) for sexually active women <25, and older with risk factors.
- Expedited partner therapy (EPT) where legal.
- Condoms reduce transmission ~90%.
- Vaccination: HPV (not gonorrhea, but co-prevention).
Early detection and guideline-concordant treatment preserve fertility. Asymptomatic infection is common—screening is essential.
Gonorrhea - Related Articles
- Endemic Goiter vs. Colloid Goiter: Causes and Differences
- Gonorrhea Treatment: Effective Antibiotic Regimens
- Gonorrhea & Strep Throat Swab Handling: Transport Media & Temperature Requirements
- Can Infection Cause Joint Fluid Loss? Understanding the Mechanism
- Gonorrhea: Why It Requires Treatment and Risks of Delay
- Tokio Hotel Members' Circumcision Status: Public Information
- Snoring Duration: Causes, Impact, and What to Expect
